University of Oulu

Pernaa N, Keskitalo S, Chowdhury I, Nissinen A, Glumoff V, Keski-Filppula R, Junttila J, Eklund KK, Santaniemi W, Siitonen S, Seppänen MRJ, Vähäsalo P, Varjosalo M, Åström P and Hautala T (2022) Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity. Front. Immunol. 13:819929. doi: 10.3389/fimmu.2022.819929

Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity

Saved in:
Author: Pernaa, Nora1; Keskitalo, Salla2; Chowdhury, Iftekhar2;
Organizations: 1Research Unit of Biomedicine, University of Oulu, Oulu, Finland
2Molecular Systems Biology Group, Institute of Biotechnology, University of Helsinki, Helsinki, Finland
3PEDEGO Research Unit, University of Oulu, Oulu, Finland
4Department of Clinical Genetics, Oulu University Hospital, Oulu, Finland
5Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
6Research Unit of Internal Medicine, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
7Department of Rheumatology, Inflammation Center, University of Helsinki and Helsinki University Hospital and Orton Orthopedic Hospital, Helsinki, Finland
8Oulun University Hospital and Research Unit of Biomedicine, University of Oulu, Oulu, Finland
9Department of Clinical Chemistry, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland
10Rare Disease Center and Pediatric Research Center, Children and Adolescents; Adult Immunodeficiency Unit, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
11Department of Pediatrics, Oulu University Hospital, Oulu, Finland
12Infectious Diseases, Oulu University Hospital and Research Unit of Biomedicine, University of Oulu, Oulu, Finland
Format: article
Version: published version
Access: open
Online Access: PDF Full Text (PDF, 6.6 MB)
Persistent link: http://urn.fi/urn:nbn:fi-fe2023063068687
Language: English
Published: Frontiers Media, 2022
Publish Date: 2023-06-30
Description:

Abstract

Krüppel-like factor 2 (KLF2) is a transcription factor with significant roles in development, maturation, differentiation, and proliferation of several cell types. In immune cells, KLF2 regulates maturation and trafficking of lymphocytes and monocytes. KLF2 participates in regulation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway. Although pulmonary arterial hypertension (PAH) related to KLF2 genetic variant has been suggested, genetic role of KLF2 associated with immune dysregulation has not been described. We identified a family whose members suffered from lymphopenia, autoimmunity, and malignancy. Whole exome sequencing revealed a KLF2 p.(Glu318Argfs*87) mutation disrupting the highly conserved zinc finger domain. We show a reduced amount of KLF2 protein, defective nuclear localization and altered protein-protein interactome. The phenotypically variable positive cases presented with B and T cell lymphopenia and abnormalities in B and T cell maturation including low naive T cell counts and low CD27⁺IgD⁻IgM⁻ switched memory B cells. KLF2 target gene (CD62L) expression was affected. Although the percentage of (CD25⁺FOXP3⁺, CD25⁺CD127⁻) regulatory T cells (Treg) was high, the naive Treg cells (CD45RA⁺) were absent. Serum IgG1 levels were low and findings in one case were consistent with common variable immunodeficiency (CVID). Transcription of NF-κβ pathway genes and p65/RelA phosphorylation were not significantly affected. Inflammasome activity, transcription of genes related with JAK/STAT pathway and interferon signature were also comparable to controls. Evidence of PAH was not found. In conclusion, KLF2 variant may be associated with familial immune dysregulation. Although the KLF2 deficient family members in our study suffered from lymphopenia, autoimmunity or malignancy, additional study cohorts are required to confirm our observations.

see all

Series: Frontiers in immunology
ISSN: 1664-3224
ISSN-E: 1664-3224
ISSN-L: 1664-3224
Volume: 13
Article number: 819929
DOI: 10.3389/fimmu.2022.819929
OADOI: https://oadoi.org/10.3389/fimmu.2022.819929
Type of Publication: A1 Journal article – refereed
Field of Science: 3111 Biomedicine
Subjects:
Funding: This study was supported by Oulu University Hospital VTR (K74809).
Copyright information: © 2022 Pernaa, Keskitalo, Chowdhury, Nissinen, Glumoff, Keski-Filppula, Junttila, Eklund, Santaniemi, Siitonen, Seppänen, Vähäsalo, Varjosalo, Åström and Hautala. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
  https://creativecommons.org/licenses/by/4.0/